Bird flu (avian influenza) : applicable recombinant DNA techniques in research and vaccine development
Peeters, B.
Tijdschrift Voor Diergeneeskunde 133(22): 956-958
2008
ISSN/ISBN: 0040-7453 PMID: 19058742 Document Number: 616630
Document emailed within 1 workday
Related Documents
Heininger, U. 2007: Protection with influenza vaccine from bird flu? Medizinische Monatsschrift für Pharmazeuten 30(11): 418Guo, W.; Xu, J.; Wu, J.; Zhao, S.; He, H.; Shi, W.; Yu, D.; Li, J.; Gao, H.; Chen, J. 2014: Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus Zhonghua Liu Xing Bing Xue Za Zhi 35(8): 949-952
Petrescu, A.L.; Cajal, N. 1984: Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route Virologie 35(4): 307-314
Chen, Z-qiu.; Lu, J-yun.; Xiao, X-cai.; Liu, H.; Di, B.; Li, K-biao.; Lu, E-jie.; Luo, L.; Yang, Z-cong. 2013: Evaluation on the risks of H5, H7 and H9 avian influenza infections in Guangzhou: using data from the 2006-2012 avian influenza surveillance program Zhonghua Liu Xing Bing Xue Za Zhi 34(9): 900-905
Monti, D.J. 1998: Veterinarians integral in resolving avian influenza incidents, developing vaccine Journal of the American Veterinary Medical Association 212(11): 1686-1687
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622
Shurygina, A.-P.S.; Leont'eva, G.F.; Grabovskaia, K.B.; Gupalova, T.V.; Koroleva, I.V.; Kramskaia, T.A.; Kiselev, O.I.; Egorov, A.I.; Suvorov, A.N. 2013: Intranasal co-administration of recombinant streptococcus group B polypeptides and influenza deltaNS1 vaccine Voprosy Virusologii 58(3): 28-31
Rudenko, L.G.; Ramirez, A.; Barro, M.; Gushchina, M.I.; Armanda, R.E.; Ermachenko, T.A.; Romanova, I.R.; Grigor'eva, E.P.; Aleksandrova, G.I.; Lonskaia, N.I. 1991: The inoculation properties of live recombinant influenza vaccine types a and B used separately and jointly in children 3 to 14 Voprosy Virusologii 36(6): 472-474
Liu, Y.; Li, Q.; He, Y-Xin.; Zhang, Y.; Wen, L-Ying.; Wang, M.; Hu, W-Fu.; Ma, M-Ying.; Wang, D-Fa.; Liu, L-Ping.; He, J.; Hu, S-Kui.; Ren, J. 2007: The firstly confirmed pregnant woman case of avian influenza A (H5N1) by etiological research in China Bing du Xue Bao 23(6): 429-433
Cassetti, M.Cristina.; Katz, J.M.; Wood, J. 2006: Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005 Vaccine 24(5): 541-543
Shablovskaia, E.A.; L'vov, D.K.; Sazonov, A.A.; Webster, R.G.; Vinograd, I.A. 1977: Isolation of influenza strains identical to influenza virus A/Anglia/42/72 from semisynanthropic bird species in Rovno Province, the Ukrainian SSR Voprosy Virusologii 4: 414-418
Zhmaeva, L.V.; Kozlov, A.I.; Iamnikova, S.S.; Kal'nov, S.L.; Verkhovskiĭ, O.A.; Aliper, T.I. 2009: Development of a diagnostic test system on the basis of sandwich ELISA for the detection of avian influenza a virus Voprosy Virusologii 54(4): 45-49
Fine, M. 2004: The Rhode Island influenza vaccine experience 1995-2003: influenza vaccine price, reimbursement, availability, and Rhode Island's influenza vaccination rate Medicine and Health Rhode Island 87(3): 79-80
Akahane, Y. 1981: Development of research on B-type hepatitis virus vaccine---including HBs antigen polypeptide vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 39(3): 619-630
Ford, A.Q.; Touchette, N.; Hall, B.Fenton.; Hwang, A.; Hombach, J. 2016: Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery Vaccine 34(13): 1489-1495
Curtiss, R.; Kelly, S.M.; Tinge, S.A.; Tacket, C.O.; Levine, M.M.; Srinivasan, J.; Koopman, M. 1994: Recombinant Salmonella vectors in vaccine development Developments in Biological Standardization 82: 23-33
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Rerks-Ngarm, S.; Pitisuttithum, P.; Ganguly, N.; Zhang, L.; Tamashiro, H.; Cooper, D.A.; Vun, M.Chhi.; Bela, B.; Ditangco, R.; Van Kinh, N.; Bernstein, A.; Osmanov, S.; Mathieson, B.; Kent, S.J.; Shao, Y. 2010: Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia Current Opinion in HIV and Aids 5(5): 435-452
Nerome, K. 1986: Development of an influenza vaccine using an artificial membrane Nihon Rinsho. Japanese Journal of Clinical Medicine 44(8): 1902-1911